[ad_1]
“Scientifically, it is very likely that the immune response generated by this vaccine can cope with a new strain of the virus,” said Ugur Sahin, one of the founders of BioNTech.
However, if necessary, “the allure of information RNA technology is that we can start developing a vaccine directly that mimics a new mutation; we could develop a new vaccine in essentially six weeks,” Sahin said.
According to Sahin, the coronavirus strain found in the UK has 9 mutations, not one as usual.
True, he said he was confident that the vaccine developed with Pfizer would be effective because “it contains more than 1,000 amino acids, and only 9 of them have changed, which means 99 percent of vaccines. the proteins are the same ”.
Studies of the new variety are currently underway and expected in two weeks.
“We are scientifically confident that the vaccine can protect, but we will only know exactly when the experiments are done. We will release the data as soon as possible, “Sahin added.
No part of this publication may be reproduced without the written permission of ELTA.
[ad_2]
